Ignite Creation Date:
2024-05-06 @ 7:46 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125041
Status:
RECRUITING
Last Update Posted:
2023-11-09
First Post:
2023-09-18
Brief Title:
Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC
Sponsor:
Qianfoshan Hospital
Organization:
Qianfoshan Hospital
Organization Data
Organization:
Qianfoshan Hospital
Class:
OTHER
Study ID:
YXLL-KY-2023102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Qianfoshan Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Jiandong Zhang
Responsible Party Title:
Director of radiotherapy departmentarchiater
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Qianfoshan Hospital
Old Name:
None
Old Organization:
None